Question 1

How many institutions own NBIO stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own NBIO shares is 0, representing N/A of the company's common stock.

Question 2

Who are the major shareholders selling Nascent Biotech, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in NBIO by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the NBIO shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned NBIO shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying NBIO stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in NBIO by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of NBIO to its portfolio, raising its holding to - shares of worth -. N/A also increased its NBIO shares holding by N/A which brought its holding to - shares worth -.

Question 4

NBIO's major insiders: who are they?

Accepted Answer

The insider with the most stakes in NBIO is HOLDEN LOWELL THOMAS , CFO at the company. Additionally, NBIO stock is highly held by  Carrick Sean and  Price Brandon among others.

Question 5

Did an insider recently sell NBIO stock?

Accepted Answer

Company executives, directors, and other insiders own 21.51% percent of Nascent Biotech, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which NBIO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include HOLDEN LOWELL THOMAS.

Question 6

Which insider recently purchased NBIO stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Nascent Biotech, Inc. insiders have bought stock, totalling 0 shares

Question 7

How much of NBIO does insiders own?

Accepted Answer

Around 0 Nascent Biotech, Inc. shares are held by insiders, which represents about 21.51% of NBIO stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

NBIO CFO, HOLDEN LOWELL THOMAS holds the largest portfolio of the company's shares. NBIO shares owned by HOLDEN total nearly 8.41 million.

Question 9

Which institution holds the most shares in NBIO?

Accepted Answer

CUBIC ASSET MANAGEMENT, LLC is the largest institutional owner in NBIO which holds 105 thousand shares worth $15.76K or 0.06% of the total NBIO shares outstanding followed by CUBIC ASSET MANAGEMENT, LLC with ownership of 105 thousand shares representing 0.06% of the NBIO ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Nascent Biotech, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the NBIO is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on NBIO's shares?

Accepted Answer

Number of NBIO shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding NBIO shares are there?

Accepted Answer

As of today, N/A shares of NBIO are outstanding.

Question 13

Is there many float in NBIO stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, NBIO has N/A shares in float.

Question 14

NBIO short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for NBIO is N/A.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	CUBIC ASSET MANAGEMENT, LLC	0.06%	105K	15.76K	0	0
Dec 31, 2023	CUBIC ASSET MANAGEMENT, LLC	0.06%	105K	18.16K	0	0

Insiders	Designation	Shares Held
HOLDEN LOWELL THOMAS	CFO	8.41M
CARRICK SEAN		1.23M
PRICE BRANDON		892.35K
KARAS DOUGLAS JOHN		10K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jun 07, 2023	HOLDEN LOWELL THOMAS	PURCHASE	0.04	130K	5.2K	8.41M
Jan 27, 2023	HOLDEN LOWELL THOMAS	PURCHASE	0.14	20K	2.8K	8.42M
Jul 21, 2022	HOLDEN LOWELL THOMAS	SALE	0.26	5K	1.3K	8.11M
Dec 26, 2019	HOLDEN LOWELL THOMAS	PURCHASE	0.17	5K	825	2.29M
Oct 03, 2019	HOLDEN LOWELL THOMAS	PURCHASE	0.14	10K	1.4K	1.41M
Oct 08, 2015	CARRICK SEAN	PURCHASE	0.20	1.5K	300	1.23M
Sep 04, 2015	PRICE BRANDON	PURCHASE	1.45	617.35K	895.15K	892.35K
Sep 04, 2015	HOLDEN LOWELL THOMAS	PURCHASE	1.45	617.35K	895.15K	717.35K
Sep 04, 2015	CARRICK SEAN	PURCHASE	1.45	1.03M	1.49M	1.23M
Apr 03, 2015	KARAS DOUGLAS JOHN	PURCHASE	1.00	10K	10K	10K

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	CUBIC ASSET MANAGEMENT, LLC	0.06%	105K	15.76K	0	0
Dec 31, 2023	CUBIC ASSET MANAGEMENT, LLC	0.06%	105K	18.16K	0	0

Insiders	Designation	Shares Held
HOLDEN LOWELL THOMAS	CFO	8.41M
CARRICK SEAN		1.23M
PRICE BRANDON		892.35K
KARAS DOUGLAS JOHN		10K

NBIO Stock Ownership Breakdown

Nascent Biotech

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions